Multiplex Assays Market to reach $3.35 Billion by 2023
The global multiplex assays market is projected to reach USD 3.35 Billion in 2023 from USD 2.17 Billion in 2017, at CAGR of 7.5%.
(firmenpresse) - What are the Global Growth Factors?
The major factors driving the growth of the Multiplex Assays Market include the adoption of companion diagnostics for increasing the safety & efficacy of therapies and the advantages of multiplex assays over conventional singleplex assays.
What The Experts Says about the Market Growth?
The global multiplex assays market is projected to reach $3.35 Billion in 2023 from USD 2.17 Billion in 2017, at CAGR of 7.5%.
Browse and in-depth TOC on "Multiplex Assays Market"
109 – Tables
32 - Figures
142 – Pages
Based on product and service, the consumables segment is accounted for the largest share of the market in 2018
On the basis of product & service, the market is broadly segmented into instruments, consumables, and software & services. In 2018, the consumables segment is expected to account for the largest share of the market; it is also the fastest-growing segment of the multiplex assays market. This can be attributed to the recurring purchase of assays and reagents for increasing research applications.
Based on technology, flow cytometry segment is expected to grow at the highest CAGR in the market during the forecast period
On the basis of technology, the global multiplex assays market is divided into flow cytometry, multiplex RT PCR, luminescence, fluorescence detection, and other technologies. In 2018, the flow cytometry segment is expected to grow at the highest CAGR in the global multiplex assays market. The high CAGR can be attributed to the wide applications of flow cytometry in detection & measurement of protein expression, RNA, cell health status (cell viability & toxicity), and characterization & identification of various cell types.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=61593314
Geographical Analysis:
North America is expected to account for the largest share of the global multiplex assays market. Asia is expected to register the highest growth rate from 2018 to 2023. This can be attributed to its pharmaceutical market which is growing at the fastest pace in the world, the availability of a large number of qualified researchers, and increasing prevalence of cancer and infectious diseases.
Key Market Players:
The key players in the global multiplex assays market include Luminex (US), Bio-Rad Laboratories (US), Becton, Dickinson (US), Illumina (US), and Thermo Fisher Scientific (US). These players focus on both organic and inorganic growth strategies such as product launches, partnerships, and agreements to maintain and enhance their market share in the market.
Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=61593314
Multiplex Assays Market by Product (Consumables, Instruments), Type (Nucleic Acid, Protein, Cell), Technology (Flow Cytometry, Luminescence), Application (R&D, Diagnosis), End User (Pharma & Biotech, Reference Laboratory, Hospital) - Global Forecast to 2023
Weitere Infos zu dieser Pressemeldung:
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
Datum: 30.09.2019 - 10:09 Uhr
Sprache: Deutsch
News-ID 1757855
Anzahl Zeichen: 3340
Kontakt-Informationen:
Ansprechpartner: Dheeraj Shaha
Stadt:
Northbrook
Telefon: 18886006441
Kategorie:
Biotechnologie
Meldungsart: Finanzinformation
Versandart: Veröffentlichung
Freigabedatum: 30.09.2019
Diese Pressemitteilung wurde bisher 398 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Multiplex Assays Market to reach $3.35 Billion by 2023"
steht unter der journalistisch-redaktionellen Verantwortung von
MnM (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
The growth of this market is mainly driven by factors such as the increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, technological advancements, and growing prevalence of diseases. The report "Microplate Systems Market by Product (Microplate R
3D Cell Culture Market : Regenerative Medicine to Offer Global Growth In Coming Years ...
A 3D cell culture is an artificially created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Factors such as rising focus on developing alternative methods for animal testing, funding initiatives from government and private
Immuno Oncology Assays : Research Application Transforming the Industrial Business ...
What the Immuno Oncology Assays Market looks like? Growth in Immuno Oncology Assays Market is largely driven by factors such as the increasing adoption of targeted therapy over traditional therapy and the increasing demand for mAbs. According to the new market research report "Immuno Onco
Weitere Mitteilungen von MnM
2nd ECP Summer Summit ...
. - Starke Teilnahme aus Ost- und Südosteuropa - Teilnehmerrekord und über 500 Partnering-Gespräche - 4th European Chemistry Partnering am 27. Februar 2020 in Frankfurt - Podcast des Panels ?Digitization in Chemistry? bald verfügbar Am 26. September 2019 trafen sich internationale Vertre
Herz-Kreislauf-Erkrankungen: Risikofaktor LDL-Cholesterin im Fokus (FOTO) ...
Die Fachgesellschaften EAS und ESC senken Zielwerte für LDL- Cholesterin weiter ab - Hintergrund der neuen Leitlinie: Je niedriger der LDL- Cholesterinwert, desto geringer ist das Risiko für kardiovaskuläre Ereignisse - Weltherztag am 29. September lenkt Aufmerksamkeit auf di
AGC Biologics ernennt neuen Standortleiter/General Manager für ihre Anlage in Chiba, Japan ...
AGC Biologics, ein weltweit führendes Unternehmen in der klinischen und kommerziellen Herstellung von therapeutischen Proteinen, gab heute die Ernennung von Naofumi Kagami zum Standortleiter/General Manager des japanischen Standorts Chiba bekannt. Herr Kagami wird die Leitung und das Standortman
Epigenetics Market to Register Substantial Expansion by 2022 ...
What are the Global Growth Factors? The key factors that are driving the growth of Epigenetics Market include the decreasing sequencing costs and time, increase in research activities to identify and develop inhibitors/drugs for various diseases, funding for epigenetics research, and rising preva
